| Section I. General Evaluation of the Hypertensive Patient |
|
|
1. Initial Evaluation of Blood Pressure |
|
|
1 | (12) |
|
John Kevin Hix, M.D., and Donald G. Vidt, M.D. |
|
|
|
2. The Use of Home Blood Pressure Monitors in Practice |
|
|
13 | (10) |
|
|
|
|
3. Urine Microalbumin: For Diabetics Only? |
|
|
23 | (14) |
|
Sunita Sharma, M.D., and Eddie L. Greene, M.D. |
|
|
| Section II. Target Organ Evaluation in the Hypertensive Patient |
|
|
4. Evaluation of Cardiac Structure and Function |
|
|
37 | (12) |
|
|
|
|
5. Assessment of Renal Function in Hypertension |
|
|
49 | (8) |
|
Meryl Waldman, M.D., and Raymond R. Townsend, M.D. |
|
|
|
6. Renal Artery Occlusive Disease in Hypertension |
|
|
57 | (10) |
|
|
|
|
7. Carotid and Peripheral Vascular Disease |
|
|
67 | (22) |
|
Robert D. Brook, M.D., Henna Kalsi, M.D., and Alan B. Weder, M.D. |
|
|
| Section III. Screening and Diagnosis of Selected Secondary Causes of Hypertension |
|
|
8. Sleep Apnea: The Not So Silent Epidemic |
|
|
89 | (10) |
|
Narayana S. Murali, M.D., Anna Svatikova, and Virend K. Somers, M.D., Ph.D. |
|
|
|
|
|
99 | (6) |
|
Marion Wofford, M.D., MPH |
|
|
| Section IV. Management of Hypertension: Goals and Objectives |
|
|
10. Treating to Goal Blood Pressure |
|
|
105 | (14) |
|
William J. Elliot, M.D., Ph. D. |
|
|
|
11. High Normal Blood Pressure |
|
|
119 | (10) |
|
Stevo Julius, M.D., Sc. D. |
|
|
|
12. Patient-related Barriers to Hypertension Control |
|
|
129 | (8) |
|
Miyong Kim, R. N., Ph.D., Martha Hill, R. N., Ph.D., and Hwayum Lee, R. N., M.P.H. |
|
|
|
13. Hypertension Control: Focus on Providers |
|
|
137 | (10) |
|
|
|
|
14. Culturally Congruent Medical Care |
|
|
147 | (8) |
|
B. Waive Kong, Ph.D., J.D., and Stephanie Kong, M.D. |
|
|
| Section V. Lifestyle Approaches: Translating Research into Practice! |
|
|
15. Promoting Lifestyle Modification in the Office Setting |
|
|
155 | (10) |
|
Lawrence J. Appel, M.D., MPH, and Edgar R. Miller, M.D., Ph.D. |
|
|
|
16. Dietary Cations and Hypertension |
|
|
165 | (16) |
|
Paul K. Muntner, Ph.D., MHS, Paul K. Whelton, M.D., M. Sc, and Jiang He, M.D., Ph.D. |
|
|
|
17. Nutrition, Dietary Supplements, and Nutraceuticals in Hypertension |
|
|
181 | (10) |
|
Mark C. Houston, M.D., SCH |
|
|
|
18 Comorbid Depression and Hypertension-related Chronic Medical Conditions |
|
|
191 | (12) |
|
Leonard E. Egede, M.D., M.S. |
|
|
|
19. Management of Obesity |
|
|
203 | (12) |
|
Patrick Mahlen O'Neil, Ph.D., and Corby K. Martin, Ph.D. |
|
|
|
20. Physical Activity for Patients with Hypertension |
|
|
215 | (8) |
|
Nancy S. Diehl, Ph.D., and Kelly R. Evenson, Ph.D. |
|
|
|
21. Behavioral Approaches in Blood Pressure Reduction |
|
|
223 | (8) |
|
Thomas Pickering, M.D., D. Phil. |
|
|
| Section VI. Medical Therapy: Evidence-Based Approach to the Important Practical Issues |
|
|
22. An Evidence-based Approach to Selecting Initial Antihypertensive Therapy |
|
|
231 | (6) |
|
|
|
|
23. Remedies for Single-Dose Therapy Failure |
|
|
237 | (6) |
|
Barry J. Materson, M.D., MBA |
|
|
|
24. The Metabolic Syndrome |
|
|
243 | (6) |
|
William H. Bestermann, Jr., M.D. |
|
|
|
25. Managing Hypertension in Diabetic Patients |
|
|
249 | (14) |
|
Peter D. Hart, M.D., and George L. Bakris, M.D. |
|
|
|
26. Isolated Systolic Hypertension |
|
|
263 | (14) |
|
Stanley S. Franklin, M.D. |
|
|
|
27. Management of Refractory Hypertension |
|
|
277 | (8) |
|
Lawrence R. Krakoff, M.D. |
|
|
| Section VII. Medical Therapy: Meeting Most Management Challenges |
|
|
28. Hypertension and Congestive Heart Failure |
|
|
285 | (12) |
|
Alan H. Gradman, M.D., and A. Tareq Khawaja, M. D. |
|
|
|
29. Managing Hypertension in Patients with Chronic Renal Insufficiency |
|
|
297 | (12) |
|
Crystal A. Gadegbeku, M.D. |
|
|
|
30. Supine Hypertension with Orthostatic Hypotension |
|
|
309 | (16) |
|
|
|
|
31. Management of Renovascular Hypertension |
|
|
325 | (10) |
|
Michael J. Bloch, M.D., and Jan Basile, M.D. |
|
|
|
32. Management of Transplant Hypertension |
|
|
335 | (10) |
|
C. Venkata S. Ram, M.D., and Pedro Vergne-Marini, M.D. |
|
|
|
33. Management of Hypertensive Patients with Sexual Dysfunction |
|
|
345 | (14) |
|
|
|
|
34. Novel Cardiovascular Risk Factors and Their Use in Clinical Practice |
|
|
359 | (10) |
|
|
|
| Section VIII. Update on Hypertension and CVD Prevention in Special Populations |
|
|
35. Hypertension in Pregnancy |
|
|
369 | (10) |
|
|
|
|
36. Preventing Cardiovascular Disease in Women |
|
|
379 | (20) |
|
Andrew P. Miller, M.D., Philippe Bouchard, and Suzanne Oparil, M.D. |
|
|
|
37. Hypertension in African Americans |
|
|
399 | (12) |
|
Elijah Saunders, M.D., Wallace Johnson, M.D., and Charlotte Jones-Burton, M.D. |
|
|
|
38. Hypertension in Adolescents |
|
|
411 | (10) |
|
|
|
|
39. Hypertension in Surgical Patients |
|
|
421 | (6) |
|
Randa K. Noseir, M.D., and Thomas J. Ebert, M.D., Ph. D. |
|
|
| Section IX. Pharmacotherapeutic Considerations: Maximizing Opportunities and Minimizing Threats |
|
|
40. Use of Nonsteroidal Anti-inflammatory Drugs in Hypertensive Patients |
|
|
427 | (8) |
|
Perry V. Halushka, Ph.D., M.D. |
|
|
|
41. Amiloride-sensitive Hypertension |
|
|
435 | (8) |
|
|
|
|
42. Adverse Drug Reactions in Patients with Hypertension |
|
|
443 | (12) |
|
|
|
| INDEX |
|
455 | |
Shopping Cart
